DNA Methylation Revolutionizes Neuroendocrine Cancer Diagnosis
Advanced DNA methylation analysis is revealing the true origins of neuroendocrine neoplasms, challenging traditional diagnostic methods. This epigenetic breakthrough could significantly improve treatment outcomes for patients with metastatic cancers of unknown primary.